ILF2 anticorps (Internal Region)
Aperçu rapide pour ILF2 anticorps (Internal Region) (ABIN190786)
Antigène
Voir toutes ILF2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Épitope
- Internal Region
-
Fonction
- ILF2 / NF45
-
Séquence
- EKAYEKPPEK KEG
-
Specificité
- This antibody is expected to recognize both reported isoforms (NP_004506.2, NP_001254738.1).
-
Réactivité croisée
- Chien, Humain, Souris, Rat
-
Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogène
- Peptide with sequence C-EKAYEKPPEKKEG, from the internal region (near the C Terminus) of the protein sequence according to NP_004506.2.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Western Blot: Approx 43 kDa band observed in Human Tonsil and Thymus lysates (calculated MW of 43.1 kDa according to NP_004506.2). Recommended concentration: 0.03-0.1 μg/mL. This antibody has been successfully used in WB in the following papers: Ye J et al
Peptide ELISA: antibody detection limit dilution 1:4000.
-
Commentaires
-
Immunoprecipitation: This antibody was confirmed by a customer in a special IP procedure called PAR-CLIP (see for method PMID: 20644507). This data is from a previous batch, not on sale.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Minimize freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
-
: "Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells." dans: Oncogene, Vol. 32, Issue 43, pp. 5176-85, (2013) (PubMed).
: "The NF90/NF45 complex participates in DNA break repair via nonhomologous end joining." dans: Molecular and cellular biology, Vol. 31, Issue 23, pp. 4832-43, (2011) (PubMed).
-
: "Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells." dans: Oncogene, Vol. 32, Issue 43, pp. 5176-85, (2013) (PubMed).
-
- ILF2 (Interleukin Enhancer Binding Factor 2, 45kDa (ILF2))
-
Autre désignation
- ILF2
-
Sujet
- ILF2, NF45, interleukin enhancer binding factor 2, 45 kDa , MGC8391, PRO3063 , interleukin enhancer binding factor 2, nuclear factor of activated T-cells, 45- kDa
-
ID gène
- 3608, 67781, 310612
-
NCBI Accession
- NP_004506, NP_001254738
Antigène
-